Searchable abstracts of presentations at key conferences in endocrinology

ea0084ps2-10-96 | Nodules & Cancer | ETA2022

Prospective, observational study on radioiodine treatment in DTC patients with intermediate RISK or micro lymph node metastases

Blewaska Aleksandra , Ledwon Aleksandra , Paliczka-Cieslik Ewa , Sygula Aleksandra , Haras-Gil Malgorzata , Kropinska Aleksandra , Czarniecka Agnieszka , Handkiewicz-Junak Daria

There are much controversy adjuvant radioiodine treatment (131-I-th) in intermediate or low risk patients with lymph node micrometastases. The first results of ESTIMABL2 trial showed no radioiodine benefit in low risk DTC, however intermediate patients were not included in this study.Aim: Observational study was to evaluate effects of 131-I-th in intermediate/low risk DTC patients.Patients: There were 342 women (85%), the median ag...

ea0035oc1.5 | Thyroid clinical | ECE2014

rh-TSH (Thyrogen) aided radioiodine therapy in children and adolescents with DTC

Handkiewicz-Junak Daria , Roskosz Jozef , Gawlik Tomasz , Olczyk Tomasz , Gubala Elzbieta , Kropinska Aleksandra , Hasse-Lazar Kornelia , Jarzab Barbara

Background: Although recombinant human TSH (rhTSH) is widely used to aid radioiodine treatment of differentiated thyroid cancer (DTC), however, there are data on its effectivness in children and adolescents with DTC.The aim of our retrospective study was to evaluate effectiveness and safety of rhTSH aided radioiodine treatment in DTC patients 18 years of age or younger.Material and Methods: Fifty five children/adolescents (median a...

ea0092ps3-27-05 | Thyroid Cancer clinical 3 | ETA2023

Changes in clinical presentation of paediatric differentiated thyroid cancer (DTC) treated in one centre over 40 years

Kropinska Aleksandra , Ledwon Aleksandra , Paliczka Cieslik Ewa , Olczyk Tomasz , Blewąska Aleksandra , Krzempek Marcela , Wilk Agata , Cortez Alexander , Czarniecka Agnieszka , Jarzab Barbara , Handkiewicz Junak Daria

Background: Differentiated thyroid carcinoma (DTC) in children is a rare cancer, occurring in 1/100,000 children/year. In the adults a steady increase in the incidence and change in presentation of DTC has been observed over the past 30 years.Purpose: Evaluation of changes in the clinical presentation of paediatric DTC on the example of children treated in Institute of Oncology in Gliwice between 1970 and 2015.Material and methods:...